Your brain's power supply may hold the key to mental illness
Dr. Bruce M. Cohen's groundbreaking research at Harvard Medical School reveals that brain metabolism may play a crucial role in understanding and treating mental disorders like schizophrenia and Alzheimer's disease.
📋 Key Points
- In an interview with Genomic Press on October 14, Dr. Bruce M. Cohen discussed his research at McLean Hospital, focusing on the metabolic processes affecting neurons in mental disorders.
- Cohen, the Robertson-Steele Professor of Psychiatry at Harvard Medical School, emphasizes the potential of induced pluripotent stem cells in studying schizophrenia and Alzheimer's disease.
- The findings suggest that disruptions in brain metabolism could be a key factor in the pathology of various neuropsychiatric conditions, reshaping treatment approaches.
- Cohen's research highlights the interplay between brain metabolism and mental disorders, opening new avenues for targeted therapies and personalized medicine in psychiatry.
💡 Why It Matters
This research signifies a shift in the understanding of mental illnesses, potentially benefiting millions affected by disorders like schizophrenia and Alzheimer's disease. By focusing on brain metabolism, future treatments may become more effective and personalized. Monitoring developments in this field could lead to innovative therapeutic strategies and improved patient outcomes.
📊 Event Details
This story is being tracked across 7 news sources.
Event ID: eng-11051324
Category: Health → Mental Health
Last Updated: October 14, 2025